Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Liquid Handling Platforms to Expand Use of 3D Cell Culture

By LabMedica International staff writers
Posted on 19 Nov 2012
Two state-of-the-art biotech companies have announced a comarketing agreement to expand the use of three-dimensional (3D) cell culture techniques through adaptation to automated liquid handling platforms.

TAP Biosystems (Cambridge, United Kingdom) will be collaborating with Tecan (Männedorf, Switzerland) to automate the TAP RAFT (Real Architecture for 3D Tissue) 3D cell culturing system for use with the Tecan Freedom EVO liquid handling platform. More...


The Tecan Freedom EVO series offers worktables with building-block modularity that ensures precision, reliable liquid handling, and easy-to-use robotics. Each platform can be combined with a wide choice of robotic arms, liquid handling tools, and application options powered by straightforward software that can be programmed to meet the needs of each individual laboratory.

The RAFT 3D cell culture system uses biologically relevant concentrations of collagen matrix to ensure cells grow and proliferate in an environment closely resembling the native tissue. By combining RAFT with the Freedom EVO to automate the preparation of the collagen matrix plus media and reagent additions, researchers will have access to a rapid, reliable process for creation of consistent and reproducible 3D cell cultures.

The RAFT system requires only three simple steps to establish 96-well cell cultures. Cells and neutralized collagen are mixed, dispensed into a 96-well culture plate and incubated to create cell-seeded hydrogels. The RAFT plate gently removes medium from the hydrogels to create 96 in vivo collagen cell cultures, which may be analyzed using a broad range of biochemical, immunological, or imaging techniques.

Kevin Moore, head of applications and solutions at Tecan, said, “We are pleased to further expand our automated 3D cell culture portfolio to include the RAFT system. Working together with TAP Biosystems, we will be able to offer a complete solution for automated 3D cell culture.”

Dr. Grant Cameron, RAFT development director at TAP Biosystems, said, “RAFT is rapidly becoming a core secondary screening technology within drug discovery. This exciting collaboration will enable researchers to expand the power of the realistic collagen environment of RAFT, with substantially increased throughput to meet their cell-based screening requirements.”

Related Links:
TAP Biosystems
Tecan



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.